
ABVC BIOPHARMA INC
ABVCNASDAQ๐ #3604 by market capEarnings Aug 18US Equity
$0.99โฒ $0.04 (+3.67%)
๐ After hours$0.99โฒ 0.00%Regular close ยท extended-hours price shown1hโ
24hโฒ 3.7%
7dโฒ 1.5%
14dโผ 2.5%
30dโผ 28.6%
1yโผ 66.3%
๐ฆMarket Cap
$26M
Small Cap
๐Revenue Growth (YoY)
+56.6%
High Growth
๐Gross Margin
0.3%
Thin
๐ตFCF Margin
21.3%
Strong
โ๏ธP/S Ratio
31.6x
Expensive
Otter Score
64
Fair
Earnings
Q2 ยท 2026Reported 2026-05-18Earnings Per Share
Actual
-0.06
Expected
โ
โ
โ
YoY โ250.00%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-0.06
โ
Q1 2026
-0.12
โ
Q4 2025
-0.05
beat
Q3 2025
-0.13
beat